Differential promotion of hematopoietic chimerism and inhibition of alloreactive T cell proliferation by combinations of anti-CD40Ligand, anti-LFA-1, everolimus, and deoxyspergualin

Transplant Immunology

Volumn 20, Issue 1-2, 2008, Pages 106-112

  Metzler, Barbara ^a   Gfeller, Patrick ^a   Wieczorek, Grazyna ^a   Katopodis, Andreas ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Bone marrow transplantation; Chimerism; Costimulation blockade; Skin specific antigens; Transplantation tolerance

Indexed keywords

15 DEOXYSPERGUALIN; ANTIBODY; CD40 LIGAND MONOCLONAL ANTIBODY; EVEROLIMUS; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1 ANTIBODY; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHIMERA; COMPARATIVE STUDY; CORRELATION ANALYSIS; DRUG POTENCY; GRAFT REJECTION; HEMATOPOIESIS; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; SKIN ALLOGRAFT; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CD40 LIGAND; CELL PROLIFERATION; CHIMERISM; GRAFT REJECTION; GUANIDINES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SIROLIMUS; SKIN TRANSPLANTATION; T-LYMPHOCYTES;

EID: 56049099996     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.07.002     Document Type: Article

References (37)

1. Wekerle T., and Sykes M. Mixed chimerism and transplantation tolerance. Annu Rev Med 52 (2001) 353-370
2. Kawai T., Andrews D., Colvin R.B., Sachs D.H., and Cosimi A.B. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 6 2 (2000) 114
3. Nicolls M.R., and Gill R.G. LFA-1 (CD11a) as a therapeutic target. Am J Transplant 6 1 (2006) 27-36
4. Fischer A., Friedrich W., Fasth A., Blanche S., Le Deist F., Girault D., et al. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report. Blood 77 2 (1991) 249-256
5. Metzler B., Gfeller P., Bigaud M., Li J., Wieczorek G., Heusser C., et al. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection. J Immunol 173 11 (2004) 7025-7036
6. Kean L.S., Hamby K., Koehn B., Lee E., Coley S., Stempora L., et al. NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation. Am J Transplant 6 2 (2006) 292-304
7. Chen T., Goldstein J.S., O'Boyle K., Whitman M.C., Brunswick M., and Kozlowski S. ICAM- 1 co-stimulation has differential effects on the activation of CD4+ and CD8+ T cells. Eur J Immunol 29 3 (1999) 809-814
8. Deeths M.J., and Mescher M.F. ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1. Eur J Immunol 29 1 (1999) 45-53
9. Vu M.D., Amanullah F., Li Y., Demirci G., Sayegh M.H., and Li X.C. Different costimulatory and growth factor requirements for CD4+ and CD8+ T cell-mediated rejection. J Immunol 173 1 (2004) 214-221
10. Hu H., Dong Y., Feng P., Fechner J., Hamawy M., and Knechtle S.J. Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. Transplantation 75 7 (2003) 1075-1077
11. Holcombe H., Mellman I., Janeway Jr. C.A., Bottomly K., and Dittel B.N. The immunosuppressive agent 15-deoxyspergualin functions by inhibiting cell cycle progression and cytokine production following naive T cell activation. J Immunol 169 9 (2002) 4982-4989
12. Diegel M.L., Nadler S.G., and Kiener P.A. In vivo administration of 15-deoxyspergulin inhibits antigen-presenting cell stimulation of T cells and NF-kappaB activation. Int Immunopharmacol 2 10 (2002) 1451-1464
13. Chiffoleau E., Beriou G., Dutartre P., Usal C., Soulillou J.P., and Cuturi M.C. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment. J Immunol 168 10 (2002) 5058-5069
14. Zhou D., O'Brien C., Shum J., Garcia B., Min W., Jevnikar A.M., et al. LF 15-0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model. Transplantation 76 4 (2003) 644-650
15. Bill J., Kanagawa O., Woodland D.L., and Palmer E. The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells. J Exp Med 169 4 (1989) 1405-1419
16. Wekerle T., Sayegh M.H., Hill J., Zhao Y., Chandraker A., Swenson K.G., et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 187 12 (1998) 2037-2044
17. Billingham R.E., Brent L., and Medawar P.B. 'Actively acquired tolerance' of foreign cells. Nature 172 (1953) 603-606
18. Boyse E.A., Lance E.M., Carswell E.A., Cooper S., and Old L.J. Rejection of skin allografts by radiation chimaeras: selective gene action in the specification of cell surface structure. Nature 227 261 (1970) 901-903
19. Luo B., Chan W.F., Shapiro A.M., and Anderson C.C. Non-myeloablative mixed chimerism approaches and tolerance, a split decision. Eur J Immunol 37 5 (2007) 1233-1242
20. Metzler B., Gfeller P., Wieczorek G., Li J., Nuesslein-Hildesheim B., Katopodis A., et al. Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure. Int Immunol 20 (2008) 633-644
21. Shirasugi N., Aramaki O., Hatano M., Suda H., Tanaka K., Inoue F., et al. Syenergistic effect of 15-deoxyspergualin with costimulation blockade on alloimmune response. Transplant Proc 36 8 (2004) 2446-2447
22. Takahara S., Jiang H., Takano Y., Kokado Y., Ishibashi M., Okuyama A., et al. The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine. Transplantation 53 4 (1992) 914-918
23. Adams A.B., Williams M.A., Jones T.R., Shirasugi N., Durham M.M., Kaech S.M., et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 111 12 (2003) 1887-1895
24. Ito H., Kurtz J., Shaffer J., and Sykes M. CD4 T cell-mediated alloresistance to fully MHC- mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway. J Immunol 166 5 (2001) 2970-2981
25. Ridge J.P., Di Rosa F., and Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393 6684 (1998) 474-478
26. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F., and Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393 6684 (1998) 478-480
27. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., and Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393 6684 (1998) 480-483
28. Bourgeois C., Rocha B., and Tanchot C. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 297 5589 (2002) 2060-2063
29. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., and Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin- 12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184 2 (1996) 747-752
30. Abraham R.T., and Wiederrecht G.J. Immunopharmacology of rapamycin. Annu Rev Immunol 14 (1996) 483-510
31. Wullschleger S., Loewith R., and Hall M.N. TOR signaling in growth and metabolism. Cell 124 3 (2006) 471-484
32. Weitz-Schmidt G., Welzenbach K., Brinkmann V., Kamata T., Kallen J., Bruns C., et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 7 6 (2001) 687-692
33. Perez O.D., Mitchell D., Jager G.C., South S., Murriel C., McBride J., et al. Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1. Nat Immunol 4 11 (2003) 1083-1092
34. Derbinski J., Schulte A., Kyewski B., and Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2 11 (2001) 1032-1039
35. Belz G.T., Behrens G.M., Smith C.M., Miller J.F., Jones C., Lejon K., et al. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 196 8 (2002) 1099-1104
36. Bonasio R., Scimone M.L., Schaerli P., Grabie N., Lichtman A.H., and von Andrian U.H. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol 7 10 (2006) 1092-1100
37. Bleul C.C., Corbeaux T., Reuter A., Fisch P., Monting J.S., and Boehm T. Formation of a functional thymus initiated by a postnatal epithelial progenitor cell. Nature 441 7096 (2006) 992-996